JTCS St. Jude Medical
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Junji Yoshida
Kenji Suzuki
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takamochi, K.
Right arrow Articles by Nishiwaki, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takamochi, K.
Right arrow Articles by Nishiwaki, Y.

J Thorac Cardiovasc Surg 2000;119:1135-1140
© 2000 The American Association for Thoracic Surgery


GENERAL THORACIC SURGERY

THE ROLE OF COMPUTED TOMOGRAPHIC SCANNING IN DIAGNOSING MEDIASTINAL NODE INVOLVEMENT IN NON–SMALL CELL LUNG CANCER

Kazuya Takamochi, MDa, Kanji Nagai, MDa, Junji Yoshida, MDa, Kenji Suzuki, MDb, Yasuhisa Ohde, MDa, Mituyo Nishimura, MDa, Kenro Takahashi, MDa, Yutaka Nishiwaki, MDa

From the Division of Thoracic Oncology,a National Cancer Center Hospital East, Chiba, and Division of Thoracic Surgery,b National Cancer Center Hospital, Tokyo, Japan.

The study was supported in part by a Grant-in-Aid for Cancer Research from the Ministry of Health and Welfare, Japan.

Address for reprints: Kazuya Takamochi, MD, Department of Thoracic Oncology, National Cancer Center Hospital East, 6-5-1, Kashiwanoha, Kashiwa, Chiba 277-8577 Japan (E-mail: ktakamoc{at}east.ncc.go.jp ).

Objectives: The reliability of computed tomographic scanning in evaluating mediastinal node involvement is controversial because of the high false result rate. We attempted to identify significant factors responsible for false-positive and false-negative scans.
Methods: From August 1992 through April 1997, 401 patients with lung cancer who underwent major lung resection and systematic lymph node dissection were enrolled in this study. We retrospectively examined mediastinal node size, tumor location, maximum tumor dimension, the presence or absence of obstructive pneumonia, atelectasis, pulmonary fibrosis, and lymph node calcification on contrast-enhanced computed tomographic scans. We identified clinical and radiologic factors responsible for the false results by using univariate and multivariable analysis.
Results: Central tumor location proved to be a significant factor of false-positive scans. Elevated carcinoembryonic antigen level and larger tumor dimension were significant factors of false-negative scans. In patients with a peripheral tumor smaller than 40 mm and normal levels of serum carcinoembryonic antigen, sensitivity, specificity, positive predictive value, and negative predictive value were 6%, 93%, 8%, and 90%, respectively. The reliability of computed tomographic scanning in this low-risk subgroup was high in detecting N0-1 disease but low in diagnosing N2 disease.
Conclusion: It is not possible to accurately diagnose N2 disease by using lymph node size on computed tomographic scanning alone, especially in patients with a central tumor, an elevated serum carcinoembryonic antigen level, or a tumor of 40 mm or larger. A preoperative invasive staging procedure is indicated in these populations and may not be indicated in the population with normal computed tomographic scan results without any of these risk factors.




This article has been cited by other articles:


Home page
ChestHome page
G. A. Silvestri, M. K. Gould, M. L. Margolis, L. T. Tanoue, D. McCrory, E. Toloza, and F. Detterbeck
Noninvasive Staging of Non-small Cell Lung Cancer: ACCP Evidenced-Based Clinical Practice Guidelines (2nd Edition)
Chest, September 1, 2007; 132(3_suppl): 178S - 201S.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S.-i. Watanabe, H. Asamura, K. Suzuki, and R. Tsuchiya
Problems in Diagnosis and Surgical Management of Clinical N1 Non-small Cell Lung Cancer
Ann. Thorac. Surg., May 1, 2005; 79(5): 1682 - 1685.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
G. Leschber, G. Holinka, and A. Linder
Video-assisted mediastinoscopic lymphadenectomy (VAMLA) - a method for systematic mediastinal lymphnode dissection
Eur. J. Cardiothorac. Surg., August 1, 2003; 24(2): 192 - 195.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
H. Kimura, N. Iwai, S. Ando, K. Kakizawa, N. Yamamoto, H. Hoshino, and T. Anayama
A prospective study of indications for mediastinoscopy in lung cancer with CT findings, tumor size, and tumor markers
Ann. Thorac. Surg., June 1, 2003; 75(6): 1734 - 1739.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
K. Takamochi, K. Nagai, J. Yoshida, K. Suzuki, Y. Ohde, M. Nishimura, S. Sasaki, and Y. Nishiwaki
Pathologic N0 status in pulmonary adenocarcinoma is predictable by combining serum carcinoembryonic antigen level and computed tomographic findings
J. Thorac. Cardiovasc. Surg., August 1, 2001; 122(2): 325 - 330.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2000 by The American Association for Thoracic Surgery.